50
Participants
Start Date
October 2, 2023
Primary Completion Date
May 14, 2025
Study Completion Date
May 14, 2025
Urolithin A
Participants in the intervention group will receive 500 mg of urolithin A twice daily for 4 weeks (1,000 mg daily in total). The supplement will be administered in the form of softgels (4 softgels daily).
Placebo
Participants in the control group will receive 0 mg of urolithin A twice daily for 4 weeks. The placebo will be administered in the form of inactive capsules (4 capsules daily).
Translational GeroScience Laboratory - O'Donoghue Research Building, Oklahoma City
University of Oklahoma
OTHER